Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens.

Francesco De Sanctis,Sara Sandri,Matteo Martini,Marta Mazzocco,Alessandra Fiore,Rosalinda Trovato,Stefano Garetto,Davide Brusa,Stefano Ugel,Silvia Sartoris

Vaccine（2018）

引用 11|浏览20

暂无评分

摘要

•56 °C hyperthermia of TRAMP-C2 tumour cells (56°T-C2) induces DAMP secretion.•Preventive vaccination with 56°T-C2-pulsed DCs improves tumour protection.•Only docetaxel plus 56°T-C2-pulsed DCs therapeutic vaccination delays tumour growth.

查看译文

关键词

Hyperthermia,Dendritic cells vaccines,Docetaxel,Prostate carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens.

Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens.